PE HUB Second Opinion

In Second Opinion, Dow Jones admits it got hacked, Paul Ryan contemplates becoming the next House Speaker and the EU will reportedly give Intel the green light for it to acquire Altera for $16.7 billion.

Apax-backed Marina Holdco invests in Zensar

Apax Partners-backed Marina Holdco has acquired a minority stake in Zensar Technologies, a tech services provider. The seller was Electra Partners Mauritius Limited, which continues to hold a minority stake in Zensar.

Procyrion inks $10 mln

Houston-based heart pump developer Procyrion Inc has closed $10 million in Series B funding. The investors included Fannin Partners and Scientific Health Development. In addition to the funding, Carter Meyer, CEO of Scientific Health Development, has been added to Procyrion’s board of directors.

NEA leads Series B round for GLAMSQUAD

New York City-based GLAMSQUAD, an on-demand beauty services provider, has raised $15 million in Series B funding. New Enterprise Associates led the round with participation from previous backers SoftBank Capital, Lerer Hippeau Ventures, Montage Ventures and AOL‘s BBG Ventures. In conjunction with the funding, Dayna Grayson, a general partner at NEA, has been added to GLAMSQUAD’s board of directors.

Stagwell acquires PR and political consulting firm SKDKnickerbocker

The Stagwell Group, an investment advisory firm formed by former Microsoft executive and political strategist Mark Penn, has acquired public relations and political consulting company SKDKnickerbocker. No financial terms were disclosed. Harris, Wiltshire & Grannis served as counsel to Stagwell on the transaction.

PE-backed LoanDepot files for IPO

California-based consumer lender LoanDepot Inc has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. Morgan Stanley, Goldman Sachs, Wells Fargo Securities, Barclays and UBS Investment Bank will serve as the lead underwriters. LoanDepot is backed by Parthenon Capital Partners.

Change Capital sells stake in Macduff to Clearwater Seafoods

Change Capital Partners has sold its stake in Macduff Shellfish Group to Clearwater Seafoods. The sale puts Macduff at a valuation of 98.4 million pounds. Based in Scotland, Macduff is a shellfish company. KPMG and Burness Paull advised Change Capital on the transaction.

Opsonix picks up $8 mln Series A

Cambridge, Massachusetts-based Opsonix, a developer of pathogen-extracting treatments focused on treating blood borne infectious diseases, has launched with $8 million in Series A funding. Baxter Ventures led the round.

Customer data hub Segment grabs $27 mln Series B

San Francisco-based Segment, a platform that collects customer data, has raised $27 million in Series B funding. Thrive Capital led the round with participation from return backers Accel Partners, Kleiner Perkins Caufield & Byers and Jon Winkelried, former president of Goldman Sachs. In addition to the funding, Will Gaybrick, chief financial officer of Stripe and general partner at Thrive Capital, has been added to Segment’s board.


PE HUB First Read

First Read ends your week with news that the Nobel Peace Prize has been awarded to Tunisian National Dialogue Quartet, Denmark’s DSV is planning on acquiring UTi for $1.35 billion and good news for shutterbugs: Adobe has developed an algorithm that removes photobombers.


PE HUB Second Opinion

In Second Opinion, Kevin McCarthy bails from the House Speaker race, Blackberry’s CEO says the company may quit handsets if it can’t make money by next year and Bill Gross sues Pimco for breach of contract.


TA Associates and Reverence Capital to buy Russell Investments for $1.15 bln

TA Associates and Reverence Capital Partners have agreed to acquire Seattle-based investment manager Russell Investments from London Stock Exchange for $1.15 billion. The deal is expected to close in the first half of 2016. As a result of the transaction, Milton Berlinski, a managing partner at Reverence Capital will join Russell Investment’s board of directors as will TA Associates’ Managing Directors Todd Crockett and Roger Kafker. J.P. Morgan and Goldman Sachs are advising LSEG and Russell Investments while Broadhaven Capital Partners is doing likewise for TA Associates and Reverence Capital.

Quartet Medicine snags $6.25 mln Series A

Cambridge, Massachusetts-based Quartet Medicine, a biotech company focused on treating chronic pain and inflammation, has raised $6.25 million in funding, bringing its total Series A tally to $23.25 million. The investors in this round included Remeditex Ventures LLC. In conjunction with the funding, Remeditex CEO John Creecy has been added to Quartet Medicine’s board of directors.


MSPE invests in CoAdvantage

Morgan Stanley Global Private Equity has acquired a majority stake in CoAdvantage, a Tampa, Florida-based professional employer organization. No financial terms were disclosed.

VC-backed CytomX Therapeutics rolls out IPO

South San Francisco-based CytomX Therapeutics, a biopharmaceutical company focused on treating cancer, has debuted its IPO after pricing its over 6.6 million shares at $12 per share. The stock began trading on the NASDAQ under the ticker symbol “CTMX.” BofA Merrill Lynch, Jefferies LLC and Cowen and Company are serving as the lead underwriters. CytomX’s backers included Fidelity Management & Research Company, Casdin Capital, Cormorant Asset Management, Deerfield Management, Tekla Healthcare Investors and Tekla Life Sciences Investors, Venrock Healthcare Capital Partners and Wellington Management Company.

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget